Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00372905
Status:
TERMINATED
Last Update Posted:
2019-09-04
First Post:
2006-09-06
Brief Title:
Phase III Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma
Sponsor:
Northwestern University
Organization:
Northwestern University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07-24
Start Date Type:
ACTUAL
Primary Completion Date:
2010-06-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-07-08
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-06
First Submit QC Date:
September 6 2006
Study First Post Date:
2006-09-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-10-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-23
Last Update Post Date:
2019-09-04
Last Update Post Date Type:
ACTUAL